ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon Print

How not to fix private health care in India

Price caps on medical devices will not stop overcharging and may hit supplies

| India

The Indian government is moving toward a cap on the prices of widely used medical devices as a way of preventing overcharging by private hospitals, an important part of the national health system. But price controls are unlikely to resolve the problem, and could damage the struggling health sector by reducing supplies.

After capping the prices of coronary stents in February, New Delhi followed up by reclassifying a wide range of other devices as drugs, including balloon catheters, syringes, heart valves and orthopedic implants, as a first step toward controlling retail prices. On Aug. 16 the retail price of orthopedic implants was cut by 65%.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Discover the all new Nikkei Asia app

  • Take your reading anywhere with offline reading functions
  • Never miss a story with breaking news alerts
  • Customize your reading experience

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more